P1.105. Epithelial–Mesenchymal Plasticity Underlies Adaptive Resistance to FLOT Chemotherapy in Esophageal Adenocarcinoma

Clicks: 18
ID: 326161
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #320 of 453 articles by views in diseases of the esophagus : official journal of the international society for diseases of the esophagus

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 453 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Topic Esophageal Cancer: Molecular Biology/Pathology Background Resistance to perioperative FLOT chemotherapy remains a major determinant of poor outcome in esophageal adenocarcinoma. Epithelial–mesenchymal plasticity (EMP) enables dynamic cell state transitions that may promote adaptive chemoresistance, yet its functional contribution to chemoresistance in esophageal adenocarcinoma remains insufficiently characterized. Methods Esophageal adenocarcinoma cell models were engineered to stably express a dual-fluorescent reporter system driven by E-cadherin and vimentin promoters, allowing real-time visualization of epithelial, mesenchymal, and hybrid epithelial/mesenchymal (E/M) states. Fluorescence-Activated Cell Sorting was used to isolate phenotypically distinct subpopulations. Sensitivity to FLOT chemotherapy was assessed using cell viability and clonogenic survival. Dynamic state transitions were evaluated following chemotherapy exposure. RNA sequencing on sorted populations will enable the identification of transcriptional programs associated with chemoresistance and EMP. Results Distinct epithelial–mesenchymal subpopulations were identified across several cellular models, with marked heterogeneity. One model, FLO1, exhibited all three phenotypic states, including a hybrid E/M population indicative of high plasticity. FLOT chemotherapy exposure induced significant phenotypic shifts toward hybrid states, accompanied by increased survival and persistence of this cell subset. These findings suggest a dynamic, reversible model of chemoresistance driven by EMP rather than fixed cell identity. Conclusion Epithelial–mesenchymal plasticity promotes adaptive resistance to FLOT chemotherapy in esophageal adenocarcinoma by enabling dynamic transitions toward therapy-tolerant states. Defining molecular programs underlying these transitions may support the development of treatment strategies that limit resistance and improve patient response to perioperative chemotherapy.
Reference Key
openalex_W7203971523 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Laurie Clauzon, Kimiya Shams, Roberta Drago, Martina Cucchiara, Dionne Blangé, Maarten Bijlsma, Simone D I Franco, Giorgio Stassi
Are you one of these authors? Claim your profile
Journal diseases of the esophagus : official journal of the international society for diseases of the esophagus
Year 2026
DOI
10.1093/dote/doag077.253
URL
https://doi.org/10.1093/dote/doag077.253
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.